---
title: "United Imaging Healthcare (688271): Won the procurement project of Shanxi Province Veterans' Rehabilitation Hospital, with a bid amount of 2.596 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288263252.md"
description: "United Imaging Healthcare announced that it won the bid for the procurement project of X-ray computed tomography equipment for the Shanxi Province Veterans Hospital, with a bid amount of 2.596 million yuan. The company mainly focuses on medical imaging diagnostic equipment and radiation therapy equipment, with a revenue of 13.8 billion yuan and a net profit of 1.869 billion yuan in 2025; in the first quarter of 2026, the revenue was 2.908 billion yuan, and the net profit was 399 million yuan"
datetime: "2026-06-01T11:20:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288263252.md)
  - [en](https://longbridge.com/en/news/288263252.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288263252.md)
generator: "portal-rs"
---

# United Imaging Healthcare (688271): Won the procurement project of Shanxi Province Veterans' Rehabilitation Hospital, with a bid amount of 2.596 million yuan

According to Tongbi Finance, data from Qichacha shows that based on the "Announcement of the Results of the Procurement Project for X-ray Computed Tomography Equipment by the Shanxi Provincial Veterans' Hospital," Shanghai United Imaging Healthcare Technology Co., Ltd. announced on June 1, 2026, that it won the bid for the procurement project of the Shanxi Provincial Veterans' Hospital, with a winning amount of 2.596 million yuan.

Related listed company: United Imaging Healthcare (688271.SH)

*Tongbi Finance Tip:*

*United Imaging Healthcare (688271.SH) reported an operating income of 13.8 billion yuan in 2025, with a growth rate of 33.98%. The net profit attributable to the parent company was 1.869 billion yuan, with a growth rate of 48.14%, and the return on equity was 9.00%.*

*In the first quarter of 2026, the company's operating income was 2.908 billion yuan, with a growth rate of 17.34%. The net profit attributable to the parent company was 399 million yuan, with a growth rate of 7.78%.*

*Currently, the company belongs to the healthcare industry, with the main product type being diagnostic and therapeutic equipment. The 2025 report indicated that the main composition of revenue came from the sales of medical imaging diagnostic equipment and radiation therapy equipment: 82.53%; maintenance revenue: 12.38%; other businesses: 4.69%; software revenue: 0.39%.*

### Related Stocks

- [688271.CN](https://longbridge.com/en/quote/688271.CN.md)

## Related News & Research

- [Pixel 11 gets in on the digicam trend](https://longbridge.com/en/news/296639212.md)
- [Carvolix, Truffle Capital launch SAF-MD Saudi-French medical cooperation program](https://longbridge.com/en/news/296812494.md)
- [Helium Evolution financing creates three new 15% shareholders: Maxey, Tough Investments, Howard](https://longbridge.com/en/news/296842566.md)
- [Acosta Verde launches shareholder preemptive rights offering at MXN 171.85 per share](https://longbridge.com/en/news/296830566.md)
- [Bioz and Xenocs Improve Researcher Product Evaluation Through On-Page Publication Insights](https://longbridge.com/en/news/296195684.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**